Slingshot News on MSN
Carbon ion therapy: Governor Ron DeSantis reveals new cutting edge cancer treatment with Mayo Clinic in Florida
Governor Ron DeSantis revealed a new cutting edge cancer treatment facility with the Mayo Clinic during a press conference ...
Clinical Trials Arena on MSN
Genespire to take rare disease gene therapy to clinic in 2026
GENE202 is a single dose gene therapy for patients with rare metabolic disease, methylmalonic acidaemia.
Pharmaceutical Technology on MSN
FDA increases manufacturing flexibility for cell and gene therapies
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
Pharmaceutical Technology on MSN
iRegene receives FDA RMAT designation for NouvNeu001 to treat Parkinson’s
The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.
Two York business owners are launching a unique initiative for employers which blends leadership coaching with occupational therapy.
Clinical Trials Arena on MSN
JPM26: Intellia Therapeutics hopeful on CRISPR safety despite patient death
Intellia Therapeutics CEO John Leonard explained the circumstances of the patient death at the JP Morgan Healthcare ...
3don MSNOpinion
Is the longevity movement promising too much? I’ve reported on cutting-edge innovation for decades — here’s what actually works
“Have you told her about the erection tracking?” echoed the voice of Bryan Johnson’s right-hand woman (and, it turns out, now ...
Feeling unhappy doesn't always mean something is 'wrong' with you — it often means something in your life needs urgent ...
Distractify on MSN
Why American celebs and athletes are flying south for cutting-edge stem cell therapy
Panama is no longer just a canal and a financial hub; it's now the epicenter of regenerative medicine's future.
At least four businesses in the inner-city neighbourhood of Bridgeland have seen break-ins or attempted break-ins so far this ...
Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.
Johnson & Johnson’s fourth-quarter sales beat expectations, led by strong growth for several newer cancer treatments, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results